Updated Jul 16, 2026
Tatsis Ourania has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $4.38M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 1.5K | $524.99 | $787K |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 260 | $486.35 | $126K |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 1.6K | $485.11 | $789K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 368 | $473.68 | $174K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 609 | $489.46 | $298K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 2.3K | $483.75 | $1.11M |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award [10b5-1] | 5.8K | $0.00 | |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 1.5K | $499.99 | $750K |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 3.8K | $487.76 | $1.86M |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 466 | $460.43 | $215K |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 2.1K | $468.41 | $1.00M |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 3.9K | $0.00 | |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 7.9K | $0.00 | |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 4.5K | $449.99 | $2.02M |
Tatsis Ourania is a corporate insider — currently tracked as EVP, Chief Reg. & Quality Off. of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($4.38M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tatsis Ourania profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.